Q Luo, J Yang, H Xu, J Shi, Z Liang, R Zhang, P Lu… - Drug Delivery, 2022 - Taylor & Francis
Sorafenib (SRB), a multikinase inhibitor, is effective in reducing experimental corneal
neovascularization (CNV) after oral administration; however, its therapeutic use in ocular …